Cytokinetics Stock Price

0.46 (2.62%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cytokinetics Inc CYTK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.46 2.62% 18.00 16:00:10
Open Price Low Price High Price Close Price Previous Close
17.48 17.26 18.19 18.00 17.54
Bid Price Ask Price Spread News
17.30 18.24 0.94 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7,218 1,345,903 $ 17.99 $ 24,206,749 1,077,837 8.00 - 30.14
Last Trade Time Type Quantity Stock Price Currency
16:22:57 priorref 246 $ 18.00 USD

Cytokinetics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.27B 70.78M 69.32M $ 26.87M $ - -2.11 -9.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Cytokinetics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYTK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week16.5918.1916.3717.04699,4331.418.5%
1 Month16.6218.3915.1716.601,125,5401.388.3%
3 Months22.6830.1414.7118.471,665,169-4.68-20.63%
6 Months20.9030.1414.7120.341,217,496-2.90-13.88%
1 Year9.7130.148.0017.701,056,3528.2985.38%
3 Years8.5530.145.7513.83647,2559.45110.53%
5 Years11.8630.145.7513.05567,7876.1451.77%

Cytokinetics Description

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatment for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.